華潤燃氣(01193.HK)建議委任畢馬威為獨立核數師
格隆匯4月13日丨華潤燃氣(01193.HK)發佈公吿,根據中國財政部及國務院國有資產監督管理委員會關於中央企業財務審計工作的相關規定,對會計師事務所連續承擔同一家中央企業財務審計業務的年期有限制。公司為中國華潤有限公司(該公司為一間中央企業)的附屬公司,而由於公司連續委聘現任獨立核數師安永會計師事務所的年期已經達到規定年限,故公司董事會建議安永會計師事務所將退任公司獨立核數師職務,自2023年5月25日舉行的公司應屆股東周年大會結束後生效,而不會被續聘。
經公司審核及風險管理委員會建議,董事會決議建議在安永會計師事務所退任後委任畢馬威會計師事務所為公司新任獨立核數師,但須獲公司股東於應屆股東周年大會上批准。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.